Early Life
Giammaria Giuliani comes from a family with a long history in the pharmaceutical industry. The family's roots in pharmaceuticals trace back to 1889 when his great-grandfather, Germano Giuliani, established the Giuliani pharmaceutical company in Milan, Italy.
Rise to Success
Giammaria Giuliani began his professional journey in 2002 at Leo Burnett (Publicis Group). In 2004, he took on the role of Executive Vice-President and Head of R&D at Giuliani SpA. Since 2014, Giuliani has evolved into a healthcare investor, holding board positions in various pharmaceutical and biotech companies. His strategic approach involves defining investment strategies aligned with the missions and values of these companies, in addition to supporting medical and scientific research projects. His investment portfolio includes a 5% stake in Royalty Pharma, the world's largest acquirer of pharmaceutical royalties. Furthermore, he and his brother Mario own stakes in Swiss investment company HBM Healthcare Investments and multiple biotech firms in the U.S..
Key Business Strategies
Giuliani's business acumen is centered around identifying and investing in promising opportunities within the healthcare sector. His significant stake in Royalty Pharma, a company that acquires revenue slices from blockbuster drugs, demonstrates his focus on value creation within the pharmaceutical landscape. He has also diversified his investments through stakes in Swiss investment company HBM Healthcare Investments and various biotech firms. The Giuliani family shares ownership of their family's pharmaceutical company, Giuliani, which was founded by their great-grandfather.
Philanthropy
Giammaria Giuliani, along with his wife Sabrina, established the Giuliani Foundation. This foundation is dedicated to advancing education, health, and economic well-being, both in Switzerland and internationally. The foundation's projects include research into cancer treatments, neurodegeneration, and HIV/AIDS. The Giuliani's have invested in the creation of the Giuliani RNA Center at Brown University to support RNA science breakthroughs.
